MedPath
Found 1 clinical trials|View Analysis
Sort by:

A Study of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults

Phase 3
Completed
Conditions
SARS-CoV-2
Interventions
Biological: Licensed Spikevax Vaccine
Biological: Investigational mRNA-1273.815
First Posted Date
2024-04-09
Last Posted Date
2024-06-13
Lead Sponsor
ModernaTX, Inc.
Target Recruit Count
215
Registration Number
NCT06354998
Locations
🇦🇺

Paratus Canberra, Canberra, Australian Capital Territory, Australia

🇦🇺

Holdsworth House, Darlinghurst, New South Wales, Australia

🇦🇺

USC Morayfield, Morayfield, Queensland, Australia

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath